Skip to content

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02841982
Enrollment
30
Registered
2016-07-22
Start date
2016-08-31
Completion date
2018-12-31
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Renal Surgery, Nerve Block, Pain Management

Brief summary

This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. between single-injection QLB(quadratus lumborum block)+ intravenous patient-controlled analgesia (IPCA) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing laparoscopic renal surgeries.

Interventions

Inject local anesthetics in between quadratus lumborum and psoas major without continuous local infusion

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan

DEVICEPAJUNK StimuLong

* 0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline. * given immediately after the correct position of the tip of the needle has been verified.

bolus: 1.5\ 2mg, lock time: 10min, 1h limitation: 6\ 8mg

Sponsors

Cui Xulei
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
17 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-70 yrs * American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo laparoscopic nephrectomy * Informed consent

Exclusion criteria

* A known allergy to the drugs being used * Coagulopathy, on anticoagulants * Analgesics intake, history of substance abuse * Participating in the investigation of another experimental agent * Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Design outcomes

Primary

MeasureTime frame
cumulative morphine consumptionwithin 48 postoperative hours

Secondary

MeasureTime frameDescription
nausea and vomiting scorewithin 24 hours after the surgery
pruritus scorewithin 24hour after the surgery
ambulation timewithin the 7 days after surgery
The pain scores determined by the numeric rating scale (NRS, 0-10)At 0, 2,4, 8, 12, 24 ,48,72hours after the surgery
quality of recovery3days and 5days after surgeryuse the self-assessment 15 item QoR scale to assess the patient's recovery
Postoperative hospital length of stayUp to 6 weeks
patient satisfaction with anesthesia48 hours after surgeryuse the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia
time of recovery of bowl movementwithin the 5 days after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026